POTASSIUM CHLORIDE 40MEQ Drug Patent Profile
✉ Email this page to a colleague
When do Potassium Chloride 40meq patents expire, and when can generic versions of Potassium Chloride 40meq launch?
Potassium Chloride 40meq is a drug marketed by Fresenius Kabi Usa, Nexus, Baxter Hlthcare, and Icu Medical Inc. and is included in sixteen NDAs.
The generic ingredient in POTASSIUM CHLORIDE 40MEQ is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POTASSIUM CHLORIDE 40MEQ?
- What are the global sales for POTASSIUM CHLORIDE 40MEQ?
- What is Average Wholesale Price for POTASSIUM CHLORIDE 40MEQ?
Summary for POTASSIUM CHLORIDE 40MEQ
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 314 |
Patent Applications: | 2,127 |
DailyMed Link: | POTASSIUM CHLORIDE 40MEQ at DailyMed |
Pharmacology for POTASSIUM CHLORIDE 40MEQ
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |